TMSP's subsidiary received the drug re-registration approval notice
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, TMSP announced that its wholly-owned subsidiary Huangshan TMSP Co., Ltd. (referred to as "Huangshan TMSP") recently received the approval notice for re-registration of several drugs, including Liuwei Dihuang Wan, issued by the Anhui Provincial Drug Administration. The acquisition of the above-mentioned drug re-registration approval notice ensures the stability and continuity of the company's drug production and sales qualifications, which has positive significance for the company's subsequent production, sales, and promotion
According to the Zhitong Finance APP, Tianshu Pharmaceutical (600671.SH) announced that its wholly-owned subsidiary Huangshan Tianshu Pharmaceutical Co., Ltd. (referred to as "Huangshan Tianshu") recently received multiple "Drug Re-registration Approval Notices" for products including Liuwei Dihuang Wan issued by the Anhui Provincial Drug Administration.
The acquisition of the above-mentioned "Re-registration Approval Notices" ensures the stability and continuity of the company's drug production and sales qualifications, which has positive significance for the company's subsequent production, sales, promotion, and other activities